Table 2 Characteristics of included studies
Author Year Country Study qualityObjective economic perspectiveStudy type Economic analysis typeInterventionParticipantsFollow-up durationEffectiveness establishedOutcome
Incremental monthly intervention costs per participantAnnual costs per participant to become active†
Elley et al 2004New Zealand HighPrimary care exercise counselling/prescriptionRCTIntervention (I): Green prescription, counselling in GPLess active primary care patients (40–79 years)12 monthsYes
  • 6.7 €

  • 825 € (Activity level: 5 × 30 minutes per week)

Health funder’s and social perspectiveCEAControl (C): usual careI: n = 451
C: n = 427
Groups comparable: Yes
Sevick et al 2007 USA HighCommunity-basedRCTIntervention 1(I1): phone-delivered intervention messagesSedentary adults (18–65 years)12 monthsYes
  • I1: 64.0 €

  • I1: 3213 €

Payer’s perspectiveCEAIntervention 2(I2): print materialI1: n = 80
  • I2: 32.4 €

  • I2: 773 € (Activity level: 5 × 30 minutes per week)

Control (C): contact controlI2: n = 81
C: n = 78
Groups comparable: Yes
Sevick et al 2000 USA GoodCommunity-basedRCTLifestyle (I1): centre-based behavioural skill trainingLess active adults (35–60 years)24 monthsLimited (no-intervention control group not available but compared with baseline)
  • I1: 18.7 €

I1: 1962 €
Payer’s perspectiveCEAStandard (I2): centre-based supervised exercise trainingn = 235
  • I2: 53.7 €

I2: 3924 € (Activity level: 5 × 30 minutes per week)
Groups comparable: n.a.
Stevens et al 1998 UK GoodPrimary care-basedRCTIntervention (I): PA consultation with exercise development officerLess active adults (45–74 years)8 monthsYes
  • 11.8 €

5358 € (Activity level: 5 × 30 minutes per week)
Payer’s perspectiveCEAControl (C): mailed information packageI: n = 363
C: n = 351
Groups comparable: Yes
Proper et al 2004 Netherlands GoodWorksite physical activity counsellingRCTIntervention (I): seven counselling sessions over 9 monthsCivil servants‡ (mean age: 44 years)9 monthsLimited (variable effectiveness over different outcome measures)
  • 33.9 €

No significant effect difference between groups observed regarding the activity level: ⩾5 × 30 minutes per week
Company perspectiveCBEControl (C): no interventionI: n = 131
CEAC: n = 168
Groups comparable: No
Dzator et al 2004 Australia FairPhysical activity/nutrition programme in community settingRCTIntervention 1 (I1): high-level, interactive interventionCouples‡ (mean age: 28–31 years)12 monthsLimited (internal validity, costing and the role of control group questionable)
  • I1: −0.1 €

No significant effect difference between groups observed regarding the activity level: exercise days per week
Direct programme costsCEAIntervention 2 (I2): low-level, mailed intervention materialI1: n = 47
  • I2: −0.2 €

Control (C): no interventionI2: n = 47
C: n = 43
Groups comparable: No
Wang et al 2004 USA FairTrail developmentCross-sectionalIntervention: development of four trails3986 trail usersTime horizon: 12 monthsLimited (no control group)
  • 5.4 € (assumption regarding trail usability: 30 years)

  • more active: 87 €

Payer’s perspectiveCEA
  • more active for health: 126 €

  • More active for weight loss: 790 € (activity level: personal appraisal by trail users in interviews)

Sims et al 2004 Australia FairPrimary care-basedRCT-based economic modellingActive script programme (I): improving systematic PA advice by GPs670 GPs advising sedentary patientsLimited (uptake assumption of GP advice to become active questionable)
  • 106.3 € (limited by unclear time horizon) (Activity level: >3300 kJ expended per week)

Health service’s perspectiveCEAControl (C): usual careGroups comparable:
CUA
  • *Compared with control group (if no controls available, compared with alternative “no intervention”)

  • †As defined in the study (activity measure)

  • ‡Variable proportion of participants reported as sufficiently active at baseline

  • CBA, cost benefit analysis; CEA, cost effectiveness analysis; CUA, cost utility analysis; GP, general practitioner; n.a., not available; PA, physical activity; RCT, randomised controlled trial.